Bristol-Myers Squibb Company
Inhibitors of indoleamine 2,3-dioxygenase and methods of their use

Last updated:

Abstract:

The present invention provides a compound of formula (II): an inhibitor of indoleamine 2,3-dioxygenase (IDO), which may be used as medicaments for the treatment of proliferative disorders, such as cancer, viral infections and/or autoimmune diseases. Its prodrugs are disclosed. ##STR00001##

Status:
Grant
Type:

Utility

Filling date:

3 Jan 2019

Issue date:

20 Sep 2022